Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Resistant starch from banana & Type 2 diabetes (T2D)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Clincal data

ACTRN12621001382864 - High‐amylose maize starch vs Native banana starch & Type 2 Diabetes (T2D)

The randomized, controlled, crossover trial demonstrated that, within the experimental conditions, resistant starch derived from bananas did not enhance glycemic control (GC) or glycemic variability (GV). To ascertain whether these results were influenced by variations in baseline microbiota or other environmental factors, further extended studies are necessary (1).

References

(1) Arias-Córdova et al. 2021 Nutrients 13: 4052

see also:
Prebiotics & Type 2 Diabetes (T2D)
[Type 2 dia…

References (Sources)

Resistant Starch Consumption Effects on Glycemic Control and Glycemic Variability in Patients with Type 2 Diabetes: A Randomized Crossover Study
Arias-Córdova et al. 2021 Nutrients 13: 4052

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!